R&D Sponsored A New Framework to Engineer Breakthrough Value for Medicines A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Digital From pilots to impact: What it really takes to scale GenAI i... It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.
Digital Balancing innovation and implementation: Embracing agentic A... A three-stage framework guides organisations through their agentic AI journey, ensuring effective ecosystem development.
Digital A well-kept secret: Applying IEPs to accelerate digital heal... Akira Endo discovered mevastatin, a cholesterol-lowering breakthrough molecule in 1973.
Sales & Marketing A five-step approach for optimising established brands' port... Established brands represent the majority of portfolios across pharma’s global affiliates that are often neglected, with revenue and profit growth untapped.
Digital Adopting AI platforms: A structured framework for thoughtful... The adoption of AI platforms, particularly in sectors such as drug discovery and healthcare, is a complex and critical process.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.